AzTrials
AzTrials

Healthy AdultNCT06795789

Multivitamin Intervention and Cognitive Function

A study testing Vitals+ (combined multivitamin and polyphenol supplement) in people with Healthy Adult and Cognitive Measures, run by Braincare Limited at 2 sites in United Kingdom.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this trial is to learn how a multivitamin combined blueberry polyphenol supplement (Vitals+) influences cognitive function in healthy adults. A secondary aim is to see how the biochemical level of nutritional factors change with the supplement. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy Adult, Cognitive Measures
What is being tested?
Vitals+ (combined multivitamin and polyphenol supplement)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
2 sitesUnited Kingdom
Study dates
1 Mar 2025to 1 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy Men and Women age >18 years
  • Newly subscribed to the nutritional supplement
  • Access to a PC or laptop with internet connection

Who cannot join

  • Unable to give informed consent
  • Consumed a nutritional supplement in past 3 months
  • Consuming > 4 portions of B-vitamin fortified foods a week
  • Pregnant or breastfeeding
  • Diagnosis of a neurological condition, such as Dementia, depression or anxiety
  • Prescribed vitamin B12 injections

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Harry R Jarrett, Ph.D contact

020 3540 0354

harry@yourheights.com

Lisa Holton, MSc contact

020 3540 0354

lisa@yourheights.com

United Kingdom2 sites
  • Heights Research and Development

    London, W1D 2LG

    Harry R Jarrett, Ph.D, 020 3540 0354, harry@yourheights.com

    Harry R Jarrett, Ph.D

  • Heights Research and Development

    London, W1D 2LG

    Harry Jarrett, Ph.D, 020 3540 0354, harry@yourheights.com

    Lisa Holton, MS.c, 020 3540 0354, lisa@yourheights.com

Other trials in United Kingdom

About this study

Official title: The Impact of a Multivitamin Combined Blueberry Polyphenol Supplement on Cognitive Function: A Pilot Study

The purpose of this trial is to learn how a multivitamin combined blueberry polyphenol supplement (Vitals+) influences cognitive function in healthy adults. A secondary aim is to see how the biochemical level of nutritional factors change with the supplement.

This study will be completed fully remote (from the participants home without in-person visits). Participants will be asked to compete three steps over the course of 3 months:

Read more

Step 1:

Participants will be asked to complete an online cognitive function game (45 minutes)

Step 2:

Participants will receive a fingertip blood sample kit in the post to measure nutritional markers in the body (requiring 8 drops of blood). They will then be asked to complete the same online cognitive function game and answer some questions about their general health (50 minutes). After this, participants will be requested to start their multivitamin (Vitals+) subscription, once a day for 3 months.

Step 3:

This final step is the same as step 2. After 3 months participants will receive another fingertip blood sample kit in the post (requiring 8 drops of blood) and asked to complete the cognitive function games again (50 minutes). This will mark the end of the study.

How these measurements responded to the multivitamin supplement will then be measured.

Read the detailed description

This study will investigate the influence of a 3 month multivitamin combined blueberry polyphenol supplement (Vitals+) on cognitive function, as measured by a validated online cognitive function test. The secondary outcome of this study is to evaluate nutritional biomarker response to the intervention. Specifically, elevated homocysteine concentrations have been reported as a risk factor for cognitive impairment and Dementia. Significant improvements in biomarker status of B-vitamins involved in homocysteine metabolism were found following intervention with this supplement (Vitals+). Therefore, it is hypothesised that the intervention will lead to reductions in homocysteine levels.

Furthermore, Vitamin D is a nutrient of concern, with deficient or suboptimal biomarker status reported across many European populations (particularly in winter months). Whilst vitamin D intervention has been shown to improve cognitive function in healthy adults. Therefore, a secondary hypothesis is that the supplement will lead to increased Vitamin D biomarker status.

It is hypothesised that any observed changes in cognitive function will be associated with changes in the biomarker response of homocysteine and Vitamin D.

Being tested
Vitals+ (combined multivitamin and polyphenol supplement)
Keywords
Multivitamin, Polyphenols, Blueberry, Cognitive Function, Homocysteine, B-vitamins, Vitamin D

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vitals+ (combined multivitamin and polyphenol supplement)Dietary supplement

    Also called Vitals+

    Multivitamin with 19 essential nutrients combined with Bilberry polyphenols

Study groups in NCT06795789
Study groupRoleWhat they receive
Vitals+ (combined multivitamin and polyphenol supplement)ExperimentalParticipants to supplement with Vitals+ multivitamin combined polyphenol supplement for 3 months
Receives: Dietary Supplement: Vitals+ (combined multivitamin and polyphenol supplement)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive Function

    A validated online Cognitive Function test will be used to assess cognition pre-post intervention

    Measured: 3 months

Secondary outcomes (2)
  1. Total homocysteine

    Total homocysteine concentrations will be measured through blood spot samples by isotopic dilution and high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS)

    Measured: 3 months

  2. Vitamin D

    Vitamin D concentrations will be measured through blood spot samples by isotopic dilution and high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS)

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2025
  2. Study start1 Mar 2025 (estimated)
  3. Primary completion1 Oct 2025 (estimated)
  4. Study completion1 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06795789
Sponsor's protocol ID
Vitals_CF_01
Status last verified
Jan 2025
First submitted
9 Jan 2025
Last updated
28 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Vitals+ (combined multivitamin and polyphenol supplement) in people with Healthy Adult and Cognitive Measures, run by Braincare Limited at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Harry R Jarrett, Ph.D (020 3540 0354, harry@yourheights.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive Function (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in